News
The US Food and Drug Administration (FDA) is reviewing a New Drug Application (NDA) for Cytokinetics' drug in oHCM with a Prescription Drug User Fee Act (PDUFA) date of 26 December 2025. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback